Tag: myeloid cells

With the recent FDA approval of Tavenos™ for ANCA-associated vasculitis, myeloid cells have become an attractive target for pharmacological interventions, being developed for the treatment of various oncological disorders London Roots Analysis... Read More

Roots Analysis has announced the addition of Myeloid Cells Targeting Therapeutics Market (2021-2035) report to its list of offerings. Presently, several medical researchers and industry stakeholders are engaged in the development... Read More